Direct-Acting Antivirals & HCV
Hep Talk by Larry Buhl
Two Agents
New direct-acting antivirals cross a major hurdle
The Antiviral Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA)…
Starting the Conversation
HEPCredefined.com provides a portal for learning about HCV
Hep Talk by Larry Buhl
It’s been said that the hepatitis C virus (HCV) is a silent killer,…
Drug+Drug
HIV/HCV drug interaction updates from CROI
by Larry Buhl
Several panels from CROI 2012 showed drug-drug interactions between new direct-acting antiviral agents for hepatitis C (HCV) and…
Don’t Fear the Treatment
HCV advocate, author & nurse Lucinda Porter offers perspectives on care
by Larry Buhl
Lucinda Porter, RN, understands viral hepatitis from both sides: as a healthcare practitioner and…
Hep C & Adult Films
Hep Talk
by Larry Buhl
Hep X
Does the porn industry have a hepatitis problem?
Actors who work for legitimate adult entertainment producers, who are mostly based in…
Blocking the Entrance
Entry inhibitors usher in a new phase of hep C research
by Larry Buhl
Future therapy for hepatitis C infection may include a variety of drugs…
Process of Elimination
As part of a comprehensive project to eliminate hepatitis C (HCV) from the country, Gilead began providing free hep C regimens containing the company’s…
Going Viral
While federal efforts move forward, hepatitis prevention remains unfunded
by Larry Buhl
During the seemingly interminable debate over health insurance reform, other health legislation was quietly…
Cutting Glass
A study links anal sex & meth to increased HCV rates among MSMs
by Larry Buhl
LifeGuide
For decades it has been the conventional wisdom that…
HCV Insurance Restrictions
LifeGuide
Hep Talk
Who Benefits?
Patient advocates decry restitutions on medications
by Larry Buhl
There is agreement in the medical community that a revolution is underway for the treatment…








